E

Eyenovia

EYEN

1.16000
USD
-0.095
(-7.57%)
مغلق
حجم التداول
3,214
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
38,900,795
أصول ذات صلة
A
ADMP
0
(0%)
0.000000 USD
A
ALIM
0.00000
(0.00%)
5.56000 USD
E
EYPT
-0.75000
(-7.58%)
9.14000 USD
G
GENE
-0.05000
(-5.88%)
0.80000 USD
NVS
0.650
(0.58%)
112.100 USD
O
OCUL
-0.40000
(-4.72%)
8.07000 USD
REGN
13.14
(1.22%)
1,091.19 USD
الأخبار المقالات

العنوان: Eyenovia

القطاع: Healthcare
الصناعة: Biotechnology
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.